{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:49:10Z","timestamp":1763786950526,"version":"3.45.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10735-025-10643-9","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:28:57Z","timestamp":1761226137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EDIL3 induced by GLIS2 suppresses the anti-tumor activity of CD8+ T cells and expedites epithelial-mesenchymal transition in thyroid cancer"],"prefix":"10.1007","volume":"56","author":[{"given":"Xu","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangfu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"10643_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cei\/uxac041","volume":"209","author":"S Cekic","year":"2022","unstructured":"Cekic S et al (2022) Increased radiosensitivity and impaired DNA repair in patients with STAT3-LOF and ZNF341 deficiency, potentially contributing to malignant transformations. Clin Exp Immunol 209:83\u201389. https:\/\/doi.org\/10.1093\/cei\/uxac041","journal-title":"Clin Exp Immunol"},{"key":"10643_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.894919","volume":"13","author":"Z Chen","year":"2022","unstructured":"Chen Z et al (2022) Immune profiling identifies CD8(+) T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer. Front Immunol 13:894919. https:\/\/doi.org\/10.3389\/fimmu.2022.894919","journal-title":"Front Immunol"},{"key":"10643_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ygyno.2021.08.010","volume":"163","author":"LP Cobb","year":"2021","unstructured":"Cobb LP et al (2021) Obesity and altered angiogenic-related gene expression in endometrial cancer. Gynecol Oncol 163:320\u2013326. https:\/\/doi.org\/10.1016\/j.ygyno.2021.08.010","journal-title":"Gynecol Oncol"},{"key":"10643_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1091733","volume":"13","author":"Y Ding","year":"2023","unstructured":"Ding Y, Wang Z, Chen C, Wang C, Li D, Qin Y (2023) The gene regulatory molecule GLIS3 in gastric cancer as a prognostic marker and be involved in the immune infiltration mechanism. Front Oncol 13:1091733. https:\/\/doi.org\/10.3389\/fonc.2023.1091733","journal-title":"Front Oncol"},{"key":"10643_CR5","doi-asserted-by":"publisher","unstructured":"Gasca J et al. (2020) EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin alpha(V)beta(3) in cancer cells Cell Death Discov 6:86 https:\/\/doi.org\/10.1038\/s41420-020-00322-x","DOI":"10.1038\/s41420-020-00322-x"},{"key":"10643_CR6","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","volume":"56","author":"JR Giles","year":"2023","unstructured":"Giles JR, Globig AM, Kaech SM, Wherry EJ (2023) CD8(+) T cells in the cancer-immunity cycle. Immunity 56:2231\u20132253. https:\/\/doi.org\/10.1016\/j.immuni.2023.09.005","journal-title":"Immunity"},{"key":"10643_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/cjop.CJOP-D-22-00076","volume":"66","author":"Q Gong","year":"2023","unstructured":"Gong Q, Li H (2023) High expression of BHLHE40 promotes immune infiltration and tumor progression in thyroid cancer. Chin J Physiol 66:153\u2013161. https:\/\/doi.org\/10.4103\/cjop.CJOP-D-22-00076","journal-title":"Chin J Physiol"},{"key":"10643_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.molmed.2019.02.010","volume":"25","author":"G Hajishengallis","year":"2019","unstructured":"Hajishengallis G, Chavakis T (2019) Del-1-regulated immune plasticity and inflammatory disorders. Trends Mol Med 25:444\u2013459. https:\/\/doi.org\/10.1016\/j.molmed.2019.02.010","journal-title":"Trends Mol Med"},{"key":"10643_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1128134","volume":"11","author":"M Hassanpour","year":"2023","unstructured":"Hassanpour M, Salybekov AA, Kobayashi S, Asahara T (2023) CD34 positive cells as endothelial progenitor cells in biology and medicine. Front Cell Dev Biol 11:1128134. https:\/\/doi.org\/10.3389\/fcell.2023.1128134","journal-title":"Front Cell Dev Biol"},{"key":"10643_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.821855","volume":"10","author":"TM Holm","year":"2022","unstructured":"Holm TM, Yeo S, Turner KM, Guan JL (2022) Targeting autophagy in thyroid cancer: EMT, apoptosis, and cancer stem cells. Front Cell Dev Biol 10:821855. https:\/\/doi.org\/10.3389\/fcell.2022.821855","journal-title":"Front Cell Dev Biol"},{"key":"10643_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08851-9","volume":"7","author":"D Jeong","year":"2017","unstructured":"Jeong D, Ban S, Oh S, Jin Lee S, Yong Park S, Koh YW (2017) Prognostic significance of EDIL3 expression and correlation with mesenchymal phenotype and microvessel density in lung adenocarcinoma. Sci Rep 7:8649. https:\/\/doi.org\/10.1038\/s41598-017-08851-9","journal-title":"Sci Rep"},{"key":"10643_CR12","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1007\/s00018-018-2841-9","volume":"75","author":"AM Jetten","year":"2018","unstructured":"Jetten AM (2018) GLIS1-3 transcription factors: critical roles in the regulation of multiple physiological processes and diseases. Cell Mol Life Sci 75:3473\u20133494. https:\/\/doi.org\/10.1007\/s00018-018-2841-9","journal-title":"Cell Mol Life Sci"},{"key":"10643_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.trecan.2019.07.005","volume":"5","author":"AM Jetten","year":"2019","unstructured":"Jetten AM (2019) Emerging roles of GLI-similar kruppel-like zinc finger transcription factors in leukemia and other cancers. Trends Cancer 5:547\u2013557. https:\/\/doi.org\/10.1016\/j.trecan.2019.07.005","journal-title":"Trends Cancer"},{"key":"10643_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.799223","volume":"11","author":"X Jia","year":"2021","unstructured":"Jia X et al (2021) Identification of a four-gene-based SERM signature for prognostic and drug sensitivity prediction in gastric cancer. Front Oncol 11:799223. https:\/\/doi.org\/10.3389\/fonc.2021.799223","journal-title":"Front Oncol"},{"key":"10643_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12022-023-09755-3","volume":"34","author":"S La Rosa","year":"2023","unstructured":"La Rosa S (2023) Diagnostic, prognostic, and predictive role of Ki67 proliferative index in neuroendocrine and endocrine neoplasms: past, present, and future. Endocr Pathol 34:79\u201397. https:\/\/doi.org\/10.1007\/s12022-023-09755-3","journal-title":"Endocr Pathol"},{"key":"10643_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00082","volume":"11","author":"D Laha","year":"2020","unstructured":"Laha D, Nilubol N, Boufraqech M (2020) New therapies for advanced thyroid cancer. Front Endocrinol (Lausanne) 11:82. https:\/\/doi.org\/10.3389\/fendo.2020.00082","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10643_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbrc.2015.10.159","volume":"468","author":"SH Lee","year":"2015","unstructured":"Lee SH, Kim DY, Jing F, Kim H, Yun CO, Han DJ, Choi EY (2015) Del-1 overexpression potentiates lung cancer cell proliferation and invasion. Biochem Biophys Res Commun 468:92\u201398. https:\/\/doi.org\/10.1016\/j.bbrc.2015.10.159","journal-title":"Biochem Biophys Res Commun"},{"key":"10643_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000485658","volume":"94","author":"SJ Lee","year":"2018","unstructured":"Lee SJ, Lee J, Kim WW, Jung JH, Park HY, Park JY, Chae YS (2018) Del-1 expression as a potential biomarker in triple-negative early breast cancer. Oncology 94:243\u2013256. https:\/\/doi.org\/10.1159\/000485658","journal-title":"Oncology"},{"issue":"12","key":"10643_CR19","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1172\/JCI137530","volume":"130","author":"X Li","year":"2020","unstructured":"Li X et al (2020) The DEL-1\/\u03b23 integrin axis promotes regulatory T cell responses during inflammation resolution. J Clin Invest 130(12):6261\u20136277. https:\/\/doi.org\/10.1172\/JCI137530","journal-title":"J Clin Invest"},{"key":"10643_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-021-00274-9","volume":"26","author":"M Li","year":"2021","unstructured":"Li M, Zhong D, Li G (2021) Regulatory role of local tissue signal Del-1 in cancer and inflammation: a review. Cell Mol Biol Lett 26:31. https:\/\/doi.org\/10.1186\/s11658-021-00274-9","journal-title":"Cell Mol Biol Lett"},{"issue":"1685\u20131700","key":"10643_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.06.005","volume":"33","author":"A Loft","year":"2021","unstructured":"Loft A et al (2021) Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication. Cell Metab 33(1685\u20131700):e1689. https:\/\/doi.org\/10.1016\/j.cmet.2021.06.005","journal-title":"Cell Metab"},{"key":"10643_CR22","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ijc.33690","volume":"149","author":"F Nabhan","year":"2021","unstructured":"Nabhan F, Dedhia PH, Ringel MD (2021) Thyroid cancer, recent advances in diagnosis and therapy. Int J Cancer 149:984\u2013992. https:\/\/doi.org\/10.1002\/ijc.33690","journal-title":"Int J Cancer"},{"key":"10643_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113084","volume":"42","author":"M Neault","year":"2023","unstructured":"Neault M et al (2023) CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax. Cell Rep 42:113084. https:\/\/doi.org\/10.1016\/j.celrep.2023.113084","journal-title":"Cell Rep"},{"key":"10643_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194947","author":"M Paolillo","year":"2019","unstructured":"Paolillo M, Schinelli S (2019) Extracellular matrix alterations in metastatic processes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20194947","journal-title":"Int J Mol Sci"},{"key":"10643_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip M, Schietinger A (2022) CD8(+) T cell differentiation and dysfunction in cancer. Nat Rev Immunol 22:209\u2013223. https:\/\/doi.org\/10.1038\/s41577-021-00574-3","journal-title":"Nat Rev Immunol"},{"key":"10643_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, Gogenur I (2021) Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy. Br J Cancer 124:359\u2013367. https:\/\/doi.org\/10.1038\/s41416-020-01048-4","journal-title":"Br J Cancer"},{"key":"10643_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","volume":"48","author":"CD Seib","year":"2019","unstructured":"Seib CD, Sosa JA (2019) Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin North Am 48:23\u201335. https:\/\/doi.org\/10.1016\/j.ecl.2018.10.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10643_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007958.pub2","volume":"2010","author":"A Tan","year":"2010","unstructured":"Tan A, Xia N, Gao F, Mo Z, Cao Y (2010) Angiogenesis-inhibitors for metastatic thyroid cancer. Cochrane Database Syst Rev 2010:CD007958. https:\/\/doi.org\/10.1002\/14651858.CD007958.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"10643_CR29","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jhep.2015.05.005","volume":"63","author":"H Xia","year":"2015","unstructured":"Xia H et al (2015) Edil3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma. J Hepatol 63:863\u2013873. https:\/\/doi.org\/10.1016\/j.jhep.2015.05.005","journal-title":"J Hepatol"},{"key":"10643_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-0240-1","volume":"9","author":"J Yao","year":"2020","unstructured":"Yao J et al (2020) Glis2 promotes colorectal cancer through repressing enhancer activation. Oncogenesis 9:57. https:\/\/doi.org\/10.1038\/s41389-020-0240-1","journal-title":"Oncogenesis"},{"key":"10643_CR31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/cen.12832","volume":"84","author":"Q Yuan","year":"2016","unstructured":"Yuan Q, Bu Q, Li G, Zhang J, Cui T, Zhu R, Mu D (2016) Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer. Clin Endocrinol (Oxf) 84:564\u2013570. https:\/\/doi.org\/10.1111\/cen.12832","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10643_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3892\/or.2018.6794","volume":"41","author":"J Yuan","year":"2019","unstructured":"Yuan J, Tan L, Yin Z, Tao K, Wang G, Shi W, Gao J (2019) GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on co-expression network analysis. Oncol Rep 41(1):191\u2013201. https:\/\/doi.org\/10.3892\/or.2018.6794","journal-title":"Oncol Rep"},{"key":"10643_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.658165","volume":"11","author":"F Zhang","year":"2021","unstructured":"Zhang F, Yu X, Lin Z, Wang X, Gao T, Teng D, Teng W (2021) Using tumor-infiltrating immune cells and a ceRNA network model to construct a prognostic analysis model of thyroid carcinoma. Front Oncol 11:658165. https:\/\/doi.org\/10.3389\/fonc.2021.658165","journal-title":"Front Oncol"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10643-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10643-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10643-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:46:30Z","timestamp":1763786790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10643-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10643"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10643-9","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"type":"print","value":"1567-2379"},{"type":"electronic","value":"1567-2387"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee of the Affiliated Huai\u2019an Hospital of Xuzhou Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"354"}}